Standard Versus Extended Lymph Node Dissection At Time of Cystectomy for MIBC

Seth Lerner, MD, FACS, Baylor College of Medicine, explains in his own words what the SWOG S1011 study suggests about the outcomes benefit of standard versus extended lymph node dissection for muscle invasive bladder cancer.

He also opines on whether there is more research needed before we can be certain of the standard-of-care potential of extended lymph node dissection.

Dr. Lerner presented the results of the SWOG S1011 study at the Society of Urologic Oncology Annual Meeting 2023.